Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study of in Vivo Distribution and Metabolic Kinetic Characterization of 89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic Sclerosis

NCT06489652 is registered in ClinicalTrials.gov with Jiangsu Renocell Biotech Company as lead sponsor.

NCT NCT06489652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06489652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study of in Vivo Distribution and Metabolic Kinetic Characterization of 89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic Sclerosis
Lead sponsor
Jiangsu Renocell Biotech Company
Phase
Phase 1
Overall status
Not yet recruiting
Start date
June 30, 2024
Completion date
May 31, 2027
Enrollment
8 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

systemic sclerosis